Companies: 10,795·Total market cap: $144.5T
Miromatrix Medical Inc.

Miromatrix Medical Inc.

MIRONASDAQHealthcare
$3.39
+$0.02(+0.59%)
Market Cap$92951088
P/E Ratio—
52W High$4.35
52W Low$0.906
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Miromatrix Medical Inc. (MIRO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MIRO · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.13miro eps ttm · miro earnings per shareEarnings history
PE Ratio (TTM)—miro pe ratio ttm · miro price to earningsPE Ratio deep dive
Revenue (TTM)958029.00miro revenue ttm · miro annual revenueFull revenue history
Dividend YieldNo Dividenddoes miro pay dividends · miro dividend yieldDividend history
Shares Outstanding20.7Mmiro shares outstanding · miro floatShares outstanding history
Next EarningsTBAmiro earnings date · miro next earningsEarnings history

Explore Miromatrix Medical Inc. Data

miro stock data · financials
Market Cap$93.0Mmiro market cap · miro valuation
Analyst Forecast$9 · Buy
DividendsNo Dividenddoes miromatrix medical inc. pay dividends · miro dividend yield
Revenue$953470+2783.54%miromatrix medical inc. annual revenue · miro revenue
EarningsEPS $-1.45-98.63%miro earnings · miro eps
PE Ratio—miro pe ratio · miro price to earnings

Financial Snapshot

Full Financials
FY 2022Revenue$953470.00▲ +2783.54% YoY
202020212022
miromatrix medical inc. revenue · miro revenue 2022
FY 2022Net Income-$30.0M▼ 100.64% YoY
202020212022
miromatrix medical inc. net income · miro profit 2022
FY 2022EPS$-1.45▼ 98.63% YoY
202020212022
miro eps · miromatrix medical inc. earnings per share 2022
TTM:Revenue: $958029.00Net Income: -$27.1MEPS: $-1.13View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis miro a buy · miro analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$9.00Low
$3.39Current
$9.00Avg Target165.49% upside
$9.00High
miro price target · miro 12 month forecast

Total: 2 · Buy rate: 100.0%

The MIRO analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $9.00, representing +165.49% upside from the current price of $3.39.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.59%
3M+175.61%
YTD+0.00%
1Y+5.33%
5Y-77.76%

About Miromatrix Medical Inc.

CEOJeffrey James Ross
IPO DateJun 24, 2021
Employees76
CountryUS
Websitemiromatrix.com

Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary p…

BiotechnologyHealthcareNASDAQUS

what is miromatrix medical inc. · miro stock overview · miromatrix medical inc. company profile · who is miromatrix medical inc. ceo · miro NASDAQ · miromatrix medical inc. headquarters · miromatrix medical inc. business segments

About Stock Overview & Key Data

Miromatrix Medical Inc. (MIRO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 24, 2021. As of the latest trading session, MIRO stock price is $3.39, with a market capitalization of $93.0M. The stock has returned +5.33% over the past 12 months and +0.00% year-to-date.

According to 2 Wall Street analysts, the consensus rating for Miromatrix Medical Inc. stock is Buy, with an average 12-month price target of $9.00. In fiscal year 2022, Miromatrix Medical Inc. reported revenue of $953470.00 and net income of -$30.0M. For detailed data — including Miromatrix Medical Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Miromatrix Medical Inc. (MIRO) stock price is $3.39. The stock is traded on NASDAQ under the ticker symbol MIRO. The 52-week range is $0.91 – $4.35.

MIRO stock priceMIRO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice